Other OTC - Delayed Quote • USD
Interpace Biosciences, Inc. (IDXG)
At close: April 26 at 3:52 PM EDT
Earnings Estimate
CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -0.53 | -- | -- |
Revenue Estimate
CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | -- | -- | 1 | -- |
Avg. Estimate | -- | -- | 121.68M | -- |
Low Estimate | -- | -- | 121.68M | -- |
High Estimate | -- | -- | 121.68M | -- |
Year Ago Sales | -- | -- | -- | 121.68M |
Sales Growth (year/est) | -- | -- | -- | -- |
Earnings History
CURRENCY IN USD | 3/31/2022 | 6/30/2022 | 9/30/2022 | |
---|---|---|---|---|
EPS Est. | -- | -0.8 | -0.52 | -0.25 |
EPS Actual | -- | -0.53 | -0.93 | -3.35 |
Difference | -- | 0.27 | -0.41 | -3.1 |
Surprise % | -- | 33.80% | -78.80% | -1,240.00% |
EPS Trend
CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 3.19 | 0 |
30 Days Ago | 0 | 0 | 3.19 | 0 |
60 Days Ago | 0 | 0 | 3.19 | 0 |
90 Days Ago | 0 | 0 | 3.19 | 0 |
EPS Revisions
CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
CURRENCY IN USD | IDXG | Industry | Sector | S&P 500 |
---|---|---|---|---|
Current Qtr. | -- | -- | -- | 6.50% |
Next Qtr. | -- | -- | -- | 12.00% |
Current Year | -- | -- | -- | 5.30% |
Next Year | -- | -- | -- | 13.10% |
Next 5 Years (per annum) | 15.00% | -- | -- | 11.09% |
Past 5 Years (per annum) | -23.06% | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
Downgrade | HC Wainwright & Co.: Buy to Neutral | 11/17/2021 |
Maintains | HC Wainwright & Co.: Buy | 4/9/2021 |
Maintains | HC Wainwright & Co.: Buy | 1/25/2021 |
Maintains | HC Wainwright & Co.: Buy | 10/22/2020 |
Maintains | HC Wainwright & Co.: Buy | 6/26/2020 |
Maintains | HC Wainwright & Co.: Buy | 4/23/2020 |
Related Tickers
PMD Psychemedics Corporation
2.5500
-2.67%
BDSX Biodesix, Inc.
1.2350
-1.98%
FONR FONAR Corporation
16.27
-3.50%
RNVA Rennova Health, Inc.
0.0001
0.00%
MYGN Myriad Genetics, Inc.
18.18
+1.11%
LONN.SW Lonza Group AG
527.80
+2.72%
FLGT Fulgent Genetics, Inc.
20.10
+0.35%
TWST Twist Bioscience Corporation
31.54
+1.48%
NVTAQ Invitae Corporation
0.0005
-94.44%
LH Laboratory Corporation of America Holdings
198.40
+0.03%